Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
An Acad Bras Cienc ; 88 Suppl 1: 653-63, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27168372

RESUMO

The contribution of Interleukin-1ß (IL-1ß) to neuronal injury induced by status epilepticus (SE) in the immature brain remains unclear. The goal of this study was to determine the hippocampal expression of IL-1ß and its type 1 receptor (IL-1RI) following SE induced by the lithium-pilocarpine model in fourteen-days-old rat pups; control animals were given an equal volume of saline instead of the convulsant. IL-1ß and IL-1RI mRNA hippocampal levels were assessed by qRT-PCR 6 and 24 h after SE or control conditions. IL-1ß and IL-1RI expression was detected in the dorsal hippocampus by immunohistochemical procedures; Fluoro-Jade B staining was carried out in parallel sections in order to detect neuronal cell death. IL-1ß mRNA expression was increased 6 h following SE, but not at 24 h; however IL-1RI mRNA expression was unaffected when comparing with the control group. IL-1ß and IL-1RI immunoreactivity was not detected in control animals. IL-1ß and IL-1RI were expressed in the CA1 pyramidal layer, the dentate gyrus granular layer and the hilus 6 h after SE, whereas injured cells were detected 24 h following seizures. Early expression of IL-1ß and IL-1RI in the hippocampus could be associated with SE-induced neuronal cell death mechanisms in the developing rat.


Assuntos
Hipocampo/metabolismo , Interleucina-1beta/metabolismo , Receptores de Interleucina-1/metabolismo , Estado Epiléptico/metabolismo , Animais , Convulsivantes , Modelos Animais de Doenças , Interleucina-1beta/genética , Lítio , Pilocarpina , RNA Mensageiro/metabolismo , Ratos , Receptores de Interleucina-1/genética , Estado Epiléptico/induzido quimicamente
2.
Rev Peru Med Exp Salud Publica ; 30(2): 262-7, 2013 Apr.
Artigo em Espanhol | MEDLINE | ID: mdl-23949513

RESUMO

Epilepsy is a neurological disorder affecting almost 1% of the world population. Experimental human and animal studies suggest that inflammation mediators, like cytokines, participate in the physiopathology of epilepsy. Interleukin-1beta (IL-1ß) could influence susceptibility for seizures, as well as neuronal death caused by seizures, although some findings are contradictory. This document reviews the current knowledge establishing a connection between IL-1ß, seizures and neuronal death.


Assuntos
Interleucina-1beta/fisiologia , Neurônios/fisiologia , Convulsões/etiologia , Animais , Morte Celular/fisiologia , Humanos
3.
Rev. peru. med. exp. salud publica ; 30(2): 262-267, abr.-jun. 2013. ilus, graf, tab
Artigo em Espanhol | LILACS, LIPECS | ID: lil-680993

RESUMO

La epilepsia es un trastorno neurológico que afecta aproximadamente al 1% de la población mundial. Estudios realizados en humanos y animales de experimentación sugieren que mediadores de inflamación, como las citocinas, participan en la fisiopatología de la epilepsia; entre ellos, la interleucina-1beta (IL-1ß) podría participar en la susceptibilidad para generar crisis convulsivas así como en la muerte neuronal causada por las convulsiones, aunque algunos hallazgos son contradictorios. En este documento se revisa el conocimiento actual que establece una relación entre la IL-1ß, las crisis convulsivas y la muerte neuronal.


Epilepsy is a neurological disorder affecting almost 1% of the world population. Experimental human and animal studies suggest that inflammation mediators, like cytokines, participate in the physiopathology of epilepsy. Interleukin-1beta (IL-1ß) could influence susceptibility for seizures, as well as neuronal death caused by seizures, although some findings are contradictory. This document reviews the current knowledge establishing a connection between IL-1ß, seizures and neuronal death.


Assuntos
Animais , Humanos , Interleucina-1beta/fisiologia , Neurônios/fisiologia , Convulsões/etiologia , Morte Celular/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA